About 400 reports

Abstract: - Global Cardiovascular Disease Monitoring and Diagnostic Devices Market to Reach $3.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cardiovascular Disease Monitoring and Diagnostic Devices estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion...

  • Cardiovascular Disease
  • Diagnostic Imaging
  • Cardiac Management
  • World
  • China
  • United States

Cholesteryl Ester Transfer Protein - Drugs In Development, 2021 Summary According to the recently published report ’Cholesteryl Ester Transfer Protein - Drugs In Development, 2021’; Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) pipeline Target constitutes close to 6 molecules....

  • Cardiovascular Disease
  • Pharmaceutical
  • Drug Development
  • World
  • Pharmaceutical Registrations
  • Cause-Specific Mortality Rate

The Cardiovascular drug market studied was anticipated to grow with a CAGR of nearly 3.8% during the forecast period. The major factors driving the growth of the market are the rising global prevalence of various coronary heart diseases such as stroke, cardiomyopathy causing a global burden of cardiac deaths and favorable reimbursement initiatives....

  • Cardiovascular Disease
  • Cardiovascular Drug
  • In-Store Retail
  • World
  • Europe
  • North America
  • APAC
  • South America
  • Middle East
  • Cause-Specific Mortality Rate
  • Elderly Population

Cardiovascular Diagnostic Testing Market by Type (Laboratory Developed Tests and In-Vitro Diagnostic Tests), Panel (Atherosclerotic Cardiovascular Disease Risk Panel with Score), and End User (Laboratory Testing Facilities, Academic Institutes, and Point-of-Care Testing Facilities): Global Opportunity Analysis and Industry Forecast,...

  • Cardiovascular Disease
  • World
  • APAC
  • Health Expenditure

Global Precision Cardiology Market to Reach $3,584.6 Million by 2031 Market Report Coverage - Precision Cardiology Market Segmentation • Offering - Product and Service • Sample - Blood and Non-Blood • Technology - Sequencing, Polymerase Chain Reaction (PCR), Microarray, and Other...

  • Cardiology
  • Cardiovascular Disease
  • World
  • North America
  • APAC

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Genomics
  • Biomarker
  • Residential Real Estate
  • Molecular Biology
  • Molecular Diagnostics
  • Clinical Trial
  • Cardiovascular Disease
  • Genetic Testing
  • World
  • China
  • United States
  • APAC

The injectable drugs market is expected to register a CAGR of nearly 11.1% during the forecast period. With an upsurge in the number of chronic diseases like diabetes and cancer, the need for drug delivery systems has risen substantially in the market. From the past one era of healthcare, biologics are increasingly becoming the driving...

  • Pharmaceutical
  • Infectious Disease
  • Biopharmaceutical
  • Monoclonal Antibody
  • Injectable Delivery
  • Cardiovascular Disease
  • Autoimmune Disease
  • Protein Therapy
  • World
  • APAC
  • Europe
  • Africa
  • South Africa
  • Drug Approval
  • Diabetes Prevalence

The global devices market is expected to reach US$ 43,334.36 million by 2028 from US$ 28,098.08 million in 2021; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The factors responsible for the cardiac monitoring devices market’s growth are an increase in the incidence of cardiovascular diseases, a rise in the surge in the...

  • Cardiovascular Disease
  • Cardiac Monitoring
  • World
  • Tobacco Consumption

Major players in the anticoagulants market are GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo, Alexion Pharmaceuticals Inc., Otsuka and Leo Pharma. The global anticoagulants market is expected to grow from $36.50 billion in 2021 to $40.34 billion in 2022 at a compound...

  • Cardiovascular Disease
  • Biopharmaceutical
  • Clinical Trial
  • Pharmacy
  • World
  • United States

Acromegaly and Gigantism - Epidemiology Forecast to 2029 Summary Acromegaly and gigantism are rare disorders of the pituitary gland, characterized by the hypersecretion of growth hormone (GH).In 98% of the cases of acromegaly and gigantism, the hypersecretion of GH results from a benign GH- secreting...

  • Cardiovascular Disease
  • Diabetes
  • Epidemiology
  • Hypertension
  • World
  • Diabetes Prevalence
  • Prescription Drug Sales

Major players in the cardiovascular medical lasers market are Boston Scientific Corp, Cardiovascular Systems, AngioDynamics, Royal Philips NV, and RA Medical Systems. The global cardiovascular medical lasers market is expected to grow from $0.10 billion in 2021 to $0.15 billion in 2022 at a compound annual growth rate (CAGR) of 44.3%....

  • Cardiology
  • Cardiovascular Disease
  • World
  • APAC
  • United States
  • United Kingdom
  • Surgical Procedures Performed

Major players in the medical tricorder market are QuantuMDx, Cloud DX, Qualcomm Technologies, Basil Leaf Technologies, Healthy.io Ltd., Ionis Pharmaceutical, Fujikura, Basler, and Hamamatsu Photonics. The global medical tricorder market is expected to grow from $4.40 billion in 2021 to $4.96 billion in 2022 at a compound annual growth...

  • Cardiovascular Disease
  • Cardiology
  • Diabetes
  • World
  • United States
  • Cause-Specific Mortality Rate

Cholesteryl Ester Transfer Protein - Pipeline Review, H2 2020 Summary According to the recently published report ’Cholesteryl Ester Transfer Protein - Pipeline Review, H2 2020’; Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) pipeline Target constitutes close to 7 molecules....

  • Cardiovascular Disease
  • Cholesterol
  • Drug Development
  • Pharmaceutical
  • World
  • Cause-Specific Mortality Rate
  • Pharmaceutical Registrations

Major players in the cardiovascular medical lasers market are Boston Scientific Corp, Cardiovascular Systems, AngioDynamics, Royal Philips NV, and RA Medical Systems. The global cardiovascular medical lasers market is expected to grow from $0.12 billion in 2020 to $0.12 billion in 2021 at a compound annual growth rate (CAGR) of 0.8%....

  • Cardiology
  • Cardiovascular Disease
  • World
  • United Kingdom
  • Surgical Procedures Performed

Major players in the anticoagulants market are GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo, Alexion Pharmaceuticals Inc., Otsuka, Leo Pharma, Eisai Co. Ltd, and Amphastar Pharmaceutica. The global anticoagulants market is expected to grow from $32.09 billion in...

  • Cardiovascular Disease
  • Biopharmaceutical
  • Clinical Trial
  • Pharmacy
  • World
  • United States

Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product, By Type Of Flow (Pulsatile Flow, Continuous Flow), By Application, By Design, By Region, And Segment Forecasts, 2021 - 2028 Ventricular Assist Device Market Growth & Trends The global ventricular assist device...

  • Cardiovascular Disease
  • Heart Failure
  • World
  • Germany
  • United States
  • Hospital Expenditure

Major players in the medical tricorder market are QuantuMDx, Cloud DX, Qualcomm Technologies, Basil Leaf Technologies, Healthy.io Ltd., Ionis Pharmaceutical, Fujikura, Basler, and Hamamatsu Photonics. The global medical tricorder market is expected to grow from $3.33 billion in 2020 to $3.76 billion in 2021 at a compound annual growth...

  • Cardiovascular Disease
  • Cardiology
  • Diabetes
  • World
  • United States
  • Cause-Specific Mortality Rate

C-Reactive Protein Testing Market by Assay Type (Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assay, and Others) and Application (Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others): Global Opportunity Analysis and Industry Forecast,...

  • Cardiovascular Disease
  • Autoimmune Disease
  • Arthritis
  • Clinical Chemistry
  • World
  • APAC
  • Smoking Prevalence

The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. By...

  • Healthcare
  • In Vitro Diagnostics
  • Pharmaceutical
  • Hospital
  • Breast Cancer
  • Biotechnology
  • Infectious Disease
  • Prostate Cancer
  • Neurodegenerative Disease
  • Cardiovascular Disease
  • Lung Cancer
  • World
  • North America
  • Europe
  • APAC
  • Cancer Incidence
  • Disposable Income

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Healthcare
  • Cardiology
  • Cardiovascular Disease
  • Cloud Computing
  • World

Major players in the ECG devices market are GE Healthcare, Koninklijke Philips N.V, Spacelabs Healthcare, CardioNet Inc, Schiller AG, Nihon Kohden Corporation, Medtronic PLC, OSI Systems, Mindray Medical International Limited, and Hill-Rom Holdings Inc. The global ecg devices market is expected to grow from $4.62 billion in 2021 to...

  • Cardiovascular Disease
  • Cardiac Monitoring
  • World
  • United States
  • APAC
  • Medical Technology Density

Myocardial Fibrosis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Fibrosis - Pipeline Review, H1 2020, provides an overview of the Myocardial Fibrosis (Cardiovascular) pipeline landscape. Myocardial fibrosis is an abnormal...

  • Therapy
  • Drug Development
  • Cardiovascular Disease
  • World
  • Drug Approval
  • Health Provider Density

Report Highlights:   - The global nutraceutical market should grow from $289.8 billion in 2021 to $438.9 billion by 2026, at compound annual growth rate (CAGR) of 8.7% for the period of 2021-2026. - The global market for weight loss products and services should grow from $254.9 billion in 2021 to reach $377.3...

  • Cardiovascular Disease
  • Public Health
  • Nutraceutical
  • Hypertension
  • World
  • Life Expectancy

The North America wearable injectors Market is projected to reach US$ 5767.51 million by 2027 from US$ 2370.52 million in 2019. The market is estimated to grow at CAGR of 11.9% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...

  • Drug Delivery
  • Cardiovascular Disease
  • Diabetes
  • Autoimmune Disease
  • Infectious Disease
  • North America
  • Chronic Disease Prevalence
  • Cancer Incidence

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Implantable Delivery
  • Cardiovascular Disease
  • Coronary Artery Disease
  • World
  • APAC
  • Europe
  • Elderly Population
  • Overweight Prevalence

Cardiac Arrhythmia Market, Global Forecast by Segment, Region (North America, Latin America, Europe, Asia Pacific and Rest of the World), End-User, & Key Players Globally, Cardiovascular diseases are the leading cause of mortality. According to the World Health Organisation, nearly 17.9 million...

  • Cardiovascular Disease
  • World
  • APAC
  • Overweight Prevalence
  • Health Expenditure

The Asia Pacific Wearable Injectors market is expected to reach US$ 2939.97 million by 2027 from US$ 1160.40 million in 2019. The market is estimated to grow at CAGR of 12.4% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...

  • Drug Delivery
  • Cardiovascular Disease
  • Autoimmune Disease
  • Hospital
  • APAC
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

Major companies in the market include Medtronic Inc., Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Cardinal Health, Inc., Johnson & Johnson, Terumo Corporation, Getinge Group, Teleflex Inc. and Becton Dickinson. The global cardiovascular drugs market is expected to grow from $146.51 billion in 2021 to $153.60...

  • Cardiovascular Drug
  • Cardiovascular Disease
  • World
  • Chronic Disease Prevalence
  • Labour Utilisation

Global Cardiopulmonary Stress Testing Systems Market 2021-2025 The analyst has been monitoring the cardiopulmonary stress testing systems market and it is poised to grow by $ 1.78 bn during 2021-2025, progressing at a CAGR of 6.78% during the forecast period. Our report on the cardiopulmonary stress testing systems market...

  • Cardiovascular Disease
  • World

Cholesteryl Ester Transfer Protein - Pipeline Review, H1 2020 Summary According to the recently published report ’Cholesteryl Ester Transfer Protein - Pipeline Review, H1 2020’; Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) pipeline Target constitutes close to 6 molecules....

  • Cardiovascular Disease
  • Cholesterol
  • Drug Development
  • Pharmaceutical
  • World
  • Diagnostic Imaging Density
  • Cause-Specific Mortality Rate